Defining and implementing strategies to establish a "new normal."
November 5-8, 2020
FHI Clinical is providing clinical operations services and expertise for the
The FHI Clinical team of Scientific Advisory Experts serves as consultants to support our global programs and operations.
Missed the webinar? Watch it now!
Missed the webinar? Watch it now!
that we've learned from previous outbreaks.
We envision a world where advances in vaccines and medicines help all people live longer, healthier lives.
We offer a unique combination of in-country technical, regulatory and cultural knowledge and an established global presence in Africa, Asia, Europe, Latin America and North America.
We adapt our processes and workflow as your study needs change. No matter how large or small the project, we remain agile and exact, because your research demands it.
We have research at our core. A subsidiary of FHI 360, we benefit from our parent company’s 40+ year history of clinical research and success in creating and growing CROs.
Our mission is to address unmet research needs and achieve maximum social impact by supporting the development of life-saving vaccines and medicines.
Let us help you enter hard-to-reach markets and access the right patient populations.
Tailored services to meet your needs, from protocol design and site assessments to trial planning, implementation and management.
Ability to address challenges across dozens of therapeutic areas, including infectious diseases (IDs), neglected tropical diseases (NTDs), emerging and reemerging diseases, and pediatric studies.
Leverage established partnerships with leading public and private medical research organizations, pharmaceutical and biotechnology companies, academic institutions, the U.S. National Institutes of Health (NIH), the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Agency for International Development (USAID).
As we monitor the rapidly changing COVID-19 situation, reliable data sources are crucial. We recommend this resource from Johns Hopkins University to better understand the pandemic’s impact.
The data sources include the World Health Organization, the U.S. Centers for Disease Control and Prevention, the European Center for Disease Prevention and Control, the National Health Commission of the People’s Republic of China, 1point3acres, Worldometers.info, BNO, state and national government health departments, local media reports, and the DXY, one of the world’s largest online communities for physicians, health care professionals, pharmacies and facilities.
October 20, 2020
Rob King of FHI Clinical recently spoke with the editor for Outsourcing-Pharma about the Oracle Health Sciences and FHI Clinical collaboration to improve clinical trial efficiency and help get therapies to market faster.
November 5-8, 2020
Attending WOCIP? Tafoya Hubbard and LaTonya Jones from FHI Clinical will be attending and would love to hear about your experiences in the pharmaceutical industry.
FHI Clinical has found that our sponsors and our own teams face a number of challenges to patient recruitment in COVID-19 trials. In this blog post, we discuss these limitations and how FHI Clinical is working with sponsors to develop strategies to address them.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA